A milestone review examining 1.4 million patients worldwide found that those who do not see the same doctor regularly are ...
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
The Shepherd’s Center of Greater Winston-Salem is offering a workshop for individuals turning 65 (as well as those who ...
The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...
HONG KONG, Jan 6 (Reuters) - China has launched a national plan to address the rapidly growing prevalence of dementia, which authorities say is becoming "a widespread societal concern" and poses ...
Worldwide, 47.5 million people live with dementia, including Alzheimer’s ... He says it’s also best to avoid some drugs and medications that affect the brain. Sleeping pills or sedatives ...
DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback